Press Releases


Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay, a new non-invasive test to monitor disease status in clinical research studies

The new test, available as a Lab Service throughout Europe and US, leverages the Gold Standard CELLSEARCH platform to enumerate Circulating Multiple Myeloma Cells from blood and offers real-time standardized monitoring of multiple myeloma in clinical research studies.

continue →

Topics: CELLSEARCH, Multiple myeloma, CMMCs, Lab Services


Menarini Silicon Biosystems announces launch of CellMag™ product line offering affordable Gold Standard Circulating Tumor Cells capture

CELLMAG – a cost effective, manual and simple approach for the enrichment and staining of extremely rare cells from blood

continue →

Topics: CTCs, CELLSEARCH, Liquid biopsy, Blood Enrichment, CellMag


DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor

Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor biopsy to optimize treatment strategy and patient outcome

continue →

Topics: CELLSEARCH, metastatic breast cancer, HER2, San Antonio Breast Cancer Symposium, CTC phenotyping


New Global Pooled Analysis Supports Clinical Utility of Circulating Tumor Cell Count for Early Monitoring of Metastatic Breast Cancer

Robust pooled analysis demonstrating how CTC count may help to optimize treatment choices

continue →

Topics: CELLSEARCH, metastatic breast cancer, global pooled analysis, San Antonio Breast Cancer Symposium


New Research Study Supports Clinical Utility of Circulating Tumor Cell Count for Metastatic Breast Cancer

First randomized clinical trial demonstrating that CTC count may help personalize treatment choices

continue →

Topics: CELLSEARCH, metastatic breast cancer, STIC


Two Studies Presented at AACR Meeting Deepen Understanding Of Cancer Mechanisms

Researchers Use Menarini’s Liquid Biopsy Technology to Find Genetic Alterations in Cancer Cells that May Improve Prognosis and Treatment

continue →

Topics: CELLSEARCH, metastatic breast cancer, Multiple myeloma, HER2, AACR


Menarini Silicon Biosystems Partners with OpGen to Broaden Distribution of CELLSEARCH Platform in North America

Strategic partnership will focus on commercializing CELLSEARCH platform for
COVID-19 related use cases, along with other COVID-19 related products

continue →



Menarini Silicon Biosystems Begins Distribution of Rapid COVID-19 Antibody Test in North America

The test detects antibodies made by the immune system in response to infection by the novel coronavirus in as little as 10 minutes

continue →

Topics: COVID-19, Coronavirus, COVID-19 Ab test, SARS-CoV-2, diagnostic


New ASCO Studies Offer Evidence for Use of Circulating Tumor Cells as a Prognostic Biomarker for Advanced Prostate and Breast Cancer

Results from prospective trials show a "clear prognostic value" for CTC counts

continue →

Topics: CTCs, CELLSEARCH, metastatic breast cancer, prostate cancer, ASCO


Menarini Silicon Biosystems Explores New Application for Circulating Endothelial Cells in COVID-19

Enumeration of Circulating Endothelial Cells (CECs) with CELLSEARCH platform may offer a new tool for investigating the role of the damaged endothelium in SARS-CoV-2 infection and clinical manifestation.

continue →

Topics: CELLSEARCH, COVID-19, CECs, Coronavirus, Circulating Endothelial Cells